Clinical Trial Update: Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating insulin glargine for improving glycemic control in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED